These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9796859)

  • 21. Comparative analysis of HIV-1 Tat variants.
    Pantano S; Carloni P
    Proteins; 2005 Feb; 58(3):638-43. PubMed ID: 15609368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
    Mujeeb A; Parslow TG; Yuan YC; James TL
    J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function.
    Wrenger S; Faust J; Mrestani-Klaus C; Brandt W; Thielitz A; Neubert K; Reinhold D
    Front Biosci; 2008 May; 13():3194-201. PubMed ID: 18508427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid modification in the HIV-1 Tat basic domain: insights from molecular dynamics and in vivo functional studies.
    Pantano S; Tyagi M; Giacca M; Carloni P
    J Mol Biol; 2002 May; 318(5):1331-9. PubMed ID: 12083521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
    Ziegler A; Blatter XL; Seelig A; Seelig J
    Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.
    Huang X; Seifert U; Salzmann U; Henklein P; Preissner R; Henke W; Sijts AJ; Kloetzel PM; Dubiel W
    J Mol Biol; 2002 Nov; 323(4):771-82. PubMed ID: 12419264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat.
    Mujeeb A; Bishop K; Peterlin BM; Turck C; Parslow TG; James TL
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8248-52. PubMed ID: 8058789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural model of the HIV-1 Tat(46-58)-TAR complex.
    Seewald MJ; Metzger AU; Willbold D; Rösch P; Sticht H
    J Biomol Struct Dyn; 1998 Dec; 16(3):683-92. PubMed ID: 10052624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
    J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.
    Mujtaba S; He Y; Zeng L; Farooq A; Carlson JE; Ott M; Verdin E; Zhou MM
    Mol Cell; 2002 Mar; 9(3):575-86. PubMed ID: 11931765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain.
    Ariumi Y; Kaida A; Hatanaka M; Shimotohno K
    Biochem Biophys Res Commun; 2001 Sep; 287(2):556-61. PubMed ID: 11554765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells.
    Reinhold D; Wrenger S; Bank U; Bühling F; Hoffmann T; Neubert K; Kraft M; Frank R; Ansorge S
    Immunobiology; 1996 Jan; 195(1):119-28. PubMed ID: 8852605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.
    Olsen GL; Edwards TE; Deka P; Varani G; Sigurdsson ST; Drobny GP
    Nucleic Acids Res; 2005; 33(11):3447-54. PubMed ID: 15961729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural rearrangements on HIV-1 Tat (32-72) TAR complex formation.
    Metzger AU; Schindler T; Willbold D; Kraft M; Steegborn C; Volkmann A; Frank RW; Rosch P
    FEBS Lett; 1996 Apr; 384(3):255-9. PubMed ID: 8617366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the equine infectious anemia virus Tat protein.
    Willbold D; Rosin-Arbesfeld R; Sticht H; Frank R; Rösch P
    Science; 1994 Jun; 264(5165):1584-7. PubMed ID: 7515512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.